Trial Profile
The effect of indacaterol on exercise tolelability
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 22 Jan 2013 New trial record